摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-3-butyl-3,4-dihydroisoquinolin-1-(2H)-one | 146470-69-1

中文名称
——
中文别名
——
英文名称
(+/-)-3-butyl-3,4-dihydroisoquinolin-1-(2H)-one
英文别名
3-butyl-3,4-dihydro-2H-isoquinolin-1-one
(+/-)-3-butyl-3,4-dihydroisoquinolin-1-(2H)-one化学式
CAS
146470-69-1
化学式
C13H17NO
mdl
——
分子量
203.284
InChiKey
QRSASMUHGYHRBX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    98-99.5 °C(Solv: ethanol (64-17-5))
  • 沸点:
    400.9±25.0 °C(Predicted)
  • 密度:
    1.019±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    (+/-)-3-butyl-3,4-dihydroisoquinolin-1-(2H)-one硫酸potassium nitrate 作用下, 以67%的产率得到(+/-)-3-butyl-7-nitro-3,4-dihydroisoquinolin-1-(2H)-one
    参考文献:
    名称:
    Exploring the active site of phenylethanolamine N-methyltransferase: 3-alkyl-7-substituted-1,2,3,4-tetrahydroisoquinoline inhibitors
    摘要:
    A series of 3 -alkyl-7 -substituted-1,2,3,4-tetrahydroisoquinolines was synthesized and these compounds were evaluated for their PNMT inhibitory potency and affinity for the (alpha(2)-adrenoceptor. 7-Nitro-, 7-bromo-, 7-aminosulfonyl-, or 7-N-2,2,2-trifluoroethylaminosulfonyl-THIQs that possess a 3-alkyl substituent that is longer than a methyl group showed decreased PNMT inhibitory potency, except for 3-propyl-7-aminosulfonyl-THIQ, which displayed excellent PNMT inhibitory potency. The rank order for selectivity (PNMT vs the alpha(2)-adrenoceptor) is 3 -alkyl -7 -aminosulfonyl-THIQs congruent to 3-alkyl-7-N-2,2,2-trifluoroethylaminosulfonyl-THIQs > 3-alkyl-7-nitro-THlQs > 3-alkyl-7-bromo-THIQs. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.11.015
  • 作为产物:
    描述:
    (+/-)-N-(methoxycarbonyl)-1-phenyl-2-aminohexane 在 PPA 作用下, 反应 0.25h, 以61%的产率得到(+/-)-3-butyl-3,4-dihydroisoquinolin-1-(2H)-one
    参考文献:
    名称:
    Exploring the active site of phenylethanolamine N-methyltransferase: 3-alkyl-7-substituted-1,2,3,4-tetrahydroisoquinoline inhibitors
    摘要:
    A series of 3 -alkyl-7 -substituted-1,2,3,4-tetrahydroisoquinolines was synthesized and these compounds were evaluated for their PNMT inhibitory potency and affinity for the (alpha(2)-adrenoceptor. 7-Nitro-, 7-bromo-, 7-aminosulfonyl-, or 7-N-2,2,2-trifluoroethylaminosulfonyl-THIQs that possess a 3-alkyl substituent that is longer than a methyl group showed decreased PNMT inhibitory potency, except for 3-propyl-7-aminosulfonyl-THIQ, which displayed excellent PNMT inhibitory potency. The rank order for selectivity (PNMT vs the alpha(2)-adrenoceptor) is 3 -alkyl -7 -aminosulfonyl-THIQs congruent to 3-alkyl-7-N-2,2,2-trifluoroethylaminosulfonyl-THIQs > 3-alkyl-7-nitro-THlQs > 3-alkyl-7-bromo-THIQs. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.11.015
点击查看最新优质反应信息

文献信息

  • Cobalt(III)-Catalyzed Regio- and Chemoselective [4 + 2]-Annulation of <i>N</i>-Chlorobenzamides/Acrylamides with 1,3-Dienes at Room Temperature
    作者:Balu Ramesh、Masilamani Jeganmohan
    DOI:10.1021/acs.joc.2c00072
    日期:2022.5.6
    Co(III)-catalyzed regio- and chemoselective redox-neutral C–H annulation of arylamides/acrylamides with 1,3-dienes is described. The present annulation reaction was well suited with a less-reactive 1,3-butadiene. By employing this protocol, pharmaceutically important 3,4-dihydroisoquinolinones were synthesized in good yields. Furthermore, the prepared 3,4-dihydroisoquinolinones were converted into
    描述了 Co(III) 催化的区域选择性和化学选择性氧化还原中性 C-H 环化芳基酰胺/丙烯酰胺与 1,3-二烯。本发明的环化反应非常适合反应性较低的 1,3-丁二烯。通过采用该协议,药学上重要的 3,4-二氢异喹啉酮以良好的收率合成。此外,制备的 3,4-二氢异喹啉酮以良好的收率转化为非常重要的环氧乙烷生物。竞争实验和动力学同位素效应 (KIE) 研究提出并支持了一个合理的机械循环。
  • DE1012605
    申请人:——
    公开号:——
    公开(公告)日:——
  • Method for the preparation of tetrahydroisoquinolone derivatives
    申请人:SMITH KLINE FRENCH LAB
    公开号:US02647902A1
    公开(公告)日:1953-08-04
  • SUBSTITUTED 2-ALKYL QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS
    申请人:Janssen Pharmaceutica NV
    公开号:EP1763518B1
    公开(公告)日:2012-01-11
查看更多